NGMD Stock Overview
A specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
NuGen Medical Devices Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.08 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.08 |
| Beta | 2.55 |
| 1 Month Change | -5.88% |
| 3 Month Change | -33.33% |
| 1 Year Change | -33.33% |
| 3 Year Change | -75.76% |
| 5 Year Change | n/a |
| Change since IPO | -73.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| NGMD | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | -11.1% | -10.2% | -3.7% |
| 1Y | -33.3% | -17.0% | 15.0% |
Return vs Industry: NGMD underperformed the Canadian Medical Equipment industry which returned -17% over the past year.
Return vs Market: NGMD underperformed the Canadian Market which returned 15% over the past year.
Price Volatility
| NGMD volatility | |
|---|---|
| NGMD Average Weekly Movement | 14.0% |
| Medical Equipment Industry Average Movement | 13.8% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: NGMD's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: NGMD's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Karen Dunlap | www.nugenmd.com |
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors.
NuGen Medical Devices Inc. Fundamentals Summary
| NGMD fundamental statistics | |
|---|---|
| Market cap | CA$17.42m |
| Earnings (TTM) | -CA$8.31m |
| Revenue (TTM) | CA$762.79k |
22.8x
P/S Ratio-2.1x
P/E RatioIs NGMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NGMD income statement (TTM) | |
|---|---|
| Revenue | CA$762.79k |
| Cost of Revenue | CA$404.17k |
| Gross Profit | CA$358.63k |
| Other Expenses | CA$8.67m |
| Earnings | -CA$8.31m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | 47.01% |
| Net Profit Margin | -1,089.45% |
| Debt/Equity Ratio | -291.4% |
How did NGMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:08 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NuGen Medical Devices Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|